Morgan E. Lorkowski
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immune cells in cancer
Papers in
-
- Nanoplatforms for cancer theranostics 6
- Nanopore and Nanochannel Transport Studies 2
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Efstathios Karathanasis (13 shared papers)Gil Covarrubias (11 shared papers)Prabhani U. Atukorale (6 shared papers)Peter A. Bielecki (6 shared papers)Taylor J. Moon (7 shared papers)Ketan B. Ghaghada (3 shared papers)Pubudu M. Peiris (5 shared papers)Shruti Raghunathan (4 shared papers)
- Journals
- Nanoscale (3 papers)Journal of Controlled Release (2 papers)Nanoscale Advances (2 papers)Nanoscale Horizons (1 paper)Journal of Materials Chemistry B (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Morgan E. Lorkowski
13 papers receiving 339 citations
Peers
Comparison fields: 5 of 57
- Biomaterials 171
- Immunology 107
- Biomedical Engineering 187
- Structural Biology 5
- Oncology 60
Countries citing papers authored by Morgan E. Lorkowski
This map shows the geographic impact of Morgan E. Lorkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan E. Lorkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan E. Lorkowski more than expected).
Fields of papers citing papers by Morgan E. Lorkowski
This network shows the impact of papers produced by Morgan E. Lorkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan E. Lorkowski. The network helps show where Morgan E. Lorkowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Morgan E. Lorkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 50 | |
| 2 | 2020 | 45 | |
| 3 | 2018 | 45 | |
| 4 | 2019 | 44 | |
| 5 | 2020 | 33 | |
| 6 | 2019 | 26 | |
| 7 | 2021 | 24 | |
| 8 | 2017 | 20 | |
| 9 | 2018 | 15 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 9 | |
| 13 | 2023 | 2 |
About Morgan E. Lorkowski
Morgan E. Lorkowski is a scholar working on Biomedical Engineering, Biomaterials, Immunology, Molecular Biology and Genetics, having authored 13 papers that have together received 340 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (6 papers), Immunotherapy and Immune Responses (4 papers), Glioma Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), interferon and immune responses (2 papers), Nanopore and Nanochannel Transport Studies (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Biomaterials (171 citations), Immunology (107 citations), Biomedical Engineering (187 citations), Structural Biology (5 citations) and Oncology (60 citations). Morgan E. Lorkowski has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Efstathios Karathanasis, Gil Covarrubias, Prabhani U. Atukorale, Peter A. Bielecki, Taylor J. Moon, Ketan B. Ghaghada, Pubudu M. Peiris, Shruti Raghunathan, Oguz Turan and William P. Schiemann. Their work appears in journals such as Nanoscale, Journal of Controlled Release, Nanoscale Advances, Nanoscale Horizons and Journal of Materials Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.